Clinical Trial Update: A Two-Part, Randomized Study of Dermacyte® Amniotic Wound Care Matrix [NA]

View source ↗

Summary

A two-part randomized study evaluating Dermacyte Amniotic Wound Care Matrix for diabetic foot ulcers; the trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Dermacyte Amniotic Wound Care Matrix

Snippet

Sponsor: Merakris Therapeutics | Conditions: Diabetic Foot Ulcer | NA | Status: NOT_YET_RECRUITING